Back to search

Article

NPAS2 Promotes MASLD and Hepatocarcinogenesis through SIRT1-Mediated PPARγ Suppression

2025-12-03

Abstract excerpt

<title>Abstract</title> <p> Emerging evidence suggests a link between circadian disruption and metabolic dysfunction-associated steatotic liver disease (MASLD), although the precise mechanisms are not yet fully understood. As a central circadian regulator, the role of NPAS2 in the pathogenesis and progression of MASLD to hepatocellular carcinoma (HCC) is not well characterized. This study aimed to clarify the fu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
42d4ae1c-14b8-528c-ad2b-b6779d2869fa
DOI
10.21203/rs.3.rs-8137044/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NPAS2 Promotes MASLD and Hepatocarcinogenesis through SIRT1-Mediated PPARγ SuppressionDOI 10.21203/rs.3.rs-8137044/v1
Select a neighboring publication to make it the new centre.